chitosan has been researched along with Allergic Encephalomyelitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbaspour-Ravasjani, S; Bani, F; Beyrampour-Basmenj, H; Ebrahimi-Kalan, A; Gao, H; Ghadiri, T; Khodakarimi, S; Rahbarghazi, R; Sadeghi, MR; Seidi, K; Sepasi, T; Talebi, M; Zarebkohan, A | 1 |
1 other study(ies) available for chitosan and Allergic Encephalomyelitis
| Article | Year |
|---|---|
CDX-modified chitosan nanoparticles remarkably reduce therapeutic dose of fingolimod in the EAE model of mice.
Topics: Animals; Chitosan; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Mice; Mice, Inbred C57BL; Nanoparticles; T-Lymphocytes | 2023 |